Alamar Biosciences, Inc.
NASDAQ:ALMRBiotechnology
+$1.11 today
- Market cap
- $2.12B
- Beta
- 0.00
- P/E (TTM)
- -47.5
- EPS (TTM)
- -$0.45
Volume 0.53M
Average 0.38M
ALMR Pre-Tax Margin
Income before tax as a percentage of revenue.
Alamar Biosciences, Inc.NASDAQ: ALMR
Pre-Tax Margin · Q2 FY2026 · quarter ended Jun 2026
Pre-tax margin at -45.2%
Pre-tax margin was -45.2% in Q2 FY2026.
Sources:Income StatementText generated from reported figures; not investment advice.
Pre-Tax Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -39.3%
- Year-over-year change
- —
| Period | Period end | Pre-Tax Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -39.3% | — |
Pre-Tax Margin vs competitors
How ALMR compares with its peers on the latest reported figures
- ALMR's FY2025 pre-tax margin of -39.3% is the 4th highest of the 8 companies compared; the peer median is -79.8%.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Sep 2026 | 18.5% | +9.8 pp | -10.0 pp | |
| LTM Sep 2026 | -10.5% | +0.9 pp | +25.2 pp | |
| LTM Sep 2026 | -28.4% | -8.0 pp | +54.6 pp | |
ALMRAlamar Biosciences, Inc. | FY2025 | -39.3% | — | — |
| LTM Mar 2026 | -79.8% | +351.9 pp | -96.4 pp | |
| LTM Mar 2026 | -101.8% | -20.3 pp | +83.6 pp | |
| LTM Mar 2026 | -468.0% | +96.8 pp | +177.7 pp | |
| LTM Mar 2026 | -5609.9% | -2686.5 pp | — | |
| FY2025 | — | — | — | |
| Peer median (excluding ALMR) | -79.8% | +0.9 pp | +39.9 pp | |
Competitors are the stored peer set for ALMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2025 Dec 2025 |
|---|---|
| Revenue | 74.21M |
| Cost of Revenue | 32.51M |
| Gross Profit | 41.71M |
| Gross Margin | 56.2% |
| Research & Development | 37.47M |
| Selling, General & Admin | 35.57M |
| Operating Expenses | 73.04M |
| Depreciation & Amortization | 3.86M |
| EBITDA | (24.89M) |
| EBITDA Margin | -33.5% |
| Operating Income | (31.33M) |
| Operating Margin | -42.2% |
| Interest Income | 2.16M |
| Interest Expense | 401K |
| Other Income / Expenses | 2.18M |
| Income Before Tax | (29.15M) |
| Pre-Tax Margin | -39.3% |
| Income Tax Expense | 665K |
| Net Income | (29.82M) |
| Net Margin | -40.2% |
| EPS (Basic) | (0.45) |
| EPS (Diluted) | (0.45) |
| Weighted Avg Shares | 66.52M |
| Weighted Avg Shares (Diluted) | 66.52M |
Alamar Biosciences, Inc.
NASDAQ:ALMR
Intrinsic Alpha fair value
Locked
Current Price
$30.51
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.